scholarly journals Local treatment of a pediatric osteosarcoma model with a 4-1BBL armed oncolytic adenovirus results in an antitumor effect and leads to immune memory

2021 ◽  
pp. molcanther.MCT-21-0565-A.2021
Author(s):  
Naiara Martínez-Vélez ◽  
Virginia Laspidea ◽  
Marta Zalacain ◽  
Sara Labiano ◽  
Marc Garcia-Moure ◽  
...  
2017 ◽  
Vol 28 (8) ◽  
pp. 690-700 ◽  
Author(s):  
Sujing Yuan ◽  
Yu Wu ◽  
Yigang Wang ◽  
Jianhua Chen ◽  
Liang Chu

2015 ◽  
Vol 22 (9) ◽  
pp. 2217-2225 ◽  
Author(s):  
Naiara Martínez-Vélez ◽  
Enric Xipell ◽  
Beatriz Vera ◽  
Arlet Acanda de la Rocha ◽  
Marta Zalacain ◽  
...  

Gene Therapy ◽  
2008 ◽  
Vol 15 (7) ◽  
pp. 484-494 ◽  
Author(s):  
L Chu ◽  
J Gu ◽  
L Sun ◽  
Q Qian ◽  
C Qian ◽  
...  

Open Medicine ◽  
2018 ◽  
Vol 14 (1) ◽  
pp. 1-9
Author(s):  
Jiali Hao ◽  
Wenjie Xie ◽  
Hui Li ◽  
Runsheng Li

AbstractProstate cancer (PCa) is the second most diagnosed cancer in Western male population. In this study, we insert mK5 (the mutational kringle5 of human plasminogen) into a DD3-promoted (differential display code 3) oncolytic adenovirus to construct OncoAd.mK5.DD3. E1A.dE1B, briefly, OAd.DD3.mK5. DD3 is one of the most prostate cancer specific promoters which can transcriptionally control adenoviral replication. mK5 has been proved to be able to inhibit the tumor angiogenesis and inhibit cell proliferation. Our results suggested that targeting PCa with OAd.DD3.mK5 elicited strong antitumor effect.


2009 ◽  
Vol 54 (7) ◽  
pp. 1606-1606 ◽  
Author(s):  
Juming Ma ◽  
Xiaoping He ◽  
Weiguo Wang ◽  
Yao Huang ◽  
Lin Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document